These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 30203625)
1. What factors affect the duration of treatment with diphenylcyclopropenone immunotherapy for common warts? Seo HM; Park HK; Kim TL; Kim JS Dermatol Ther; 2018 Nov; 31(6):e12740. PubMed ID: 30203625 [No Abstract] [Full Text] [Related]
2. Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Rampen FH; Steijlen PM Dermatology; 1996; 193(3):236-8. PubMed ID: 8944347 [TBL] [Abstract][Full Text] [Related]
3. Factors contributing to the treatment duration of diphenylcyclopropenone immunotherapy for periungual warts. Park HK; Kim JS Dermatol Ther; 2016; 29(2):114-9. PubMed ID: 26556040 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of disseminated facial verrucae with contact immunotherapy. Weisshaar E; Neumann HJ; Gollnick H Eur J Dermatol; 1998; 8(7):488-91. PubMed ID: 9854160 [TBL] [Abstract][Full Text] [Related]
5. Intralesional 2% zinc sulfate solution for plane warts: A case report. El Taweel AA; Salem R; Allam A Dermatol Ther; 2019 Jan; 32(1):e12761. PubMed ID: 30288881 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of periungual warts with topical cidofovir. Padilla España L; Del Boz J; Fernández Morano T; Arenas-Villafranca J; de Troya M Dermatol Ther; 2014; 27(6):337-42. PubMed ID: 25081902 [TBL] [Abstract][Full Text] [Related]
7. Diphenciprone as a therapeutic alternative to exuberant periungual warts. Souza BCE; Ribeiro CP; Swiczar BCC; Pires MC An Bras Dermatol; 2018 Mar; 93(2):305-307. PubMed ID: 29723375 [No Abstract] [Full Text] [Related]
8. Topical immunotherapy: unapproved uses, dosages, or indications. Higgins E; du Vivier A Clin Dermatol; 2002; 20(5):515-21. PubMed ID: 12435522 [No Abstract] [Full Text] [Related]
9. Comparison of cure rates and durations of treatment with diphenylcyclopropenone immunotherapy for warts in children/adolescents and adults. Kang HS; Lee MW; Paek JO; Yu HJ; Kim JS Int J Dermatol; 2014 Oct; 53(10):1293-8. PubMed ID: 24697739 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of urticaria after diphencyprone therapy in patients with viral warts. Choi JE; Seo SH; Kim IH; Son SW Int J Dermatol; 2007 Dec; 46(12):1313-4. PubMed ID: 18173535 [No Abstract] [Full Text] [Related]
11. Imiquimod for plantar and periungual warts. Sparling JD; Checketts SR; Chapman MS Cutis; 2001 Dec; 68(6):397-9. PubMed ID: 11775772 [TBL] [Abstract][Full Text] [Related]
12. The use of diphenylcyclopropenone in the treatment of recalcitrant warts. Upitis JA; Krol A J Cutan Med Surg; 2002; 6(3):214-7. PubMed ID: 11951129 [TBL] [Abstract][Full Text] [Related]
13. Treatment of disseminated facial warts through contact immunotherapy with diphenylcyclopropenone (DPCP). Aghaei S Dermatol Online J; 2006 Feb; 12(2):10. PubMed ID: 16638403 [TBL] [Abstract][Full Text] [Related]
14. An interesting response to diphencyprone (DPC) sensitization on facial warts: review of DPC treatment for viral warts. Pollock B; Highet AS J Dermatolog Treat; 2002 Jun; 13(2):47-50. PubMed ID: 12060501 [TBL] [Abstract][Full Text] [Related]
16. Erythema multiforme-like reaction following diphencyprone treatment of plane warts. Puig L; Alegre M; Cuatrecasas M; De Moragas JM Int J Dermatol; 1994 Mar; 33(3):201-3. PubMed ID: 8169024 [No Abstract] [Full Text] [Related]
17. Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts. Suh DW; Lew BL; Sim WY Int J Dermatol; 2014 Dec; 53(12):e567-71. PubMed ID: 25427069 [TBL] [Abstract][Full Text] [Related]
18. Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart. Morales-Raya C; Maroñas-Jiménez L; Aragón-Miguel R; Postigo-Llorente C Actas Dermosifiliogr; 2017 Dec; 108(10):966-968. PubMed ID: 28709617 [No Abstract] [Full Text] [Related]
19. Is the step-up therapy of topical 5-aminolevulinic acid photodynamic therapy effective and safe for the patients with recalcitrant facial flat wart? Qian G; Wang S; Deng D; Yang G Dermatol Ther; 2014; 27(2):83-8. PubMed ID: 24703264 [TBL] [Abstract][Full Text] [Related]
20. An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts. Micali G; Dall'Oglio F; Nasca MR J Dermatolog Treat; 2003 Dec; 14(4):233-6. PubMed ID: 14660271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]